- Home
- CDTX vs FUND Comparison
CDTX vs FUND Comparison
Compare CDTX & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- FUND
- Stock Information
- Founded
- CDTX 2012
- FUND 1988
- Country
- CDTX United States
- FUND Canada
- Employees
- CDTX N/A
- FUND N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FUND Investment Managers
- Sector
- CDTX Health Care
- FUND Finance
- Exchange
- CDTX Nasdaq
- FUND Nasdaq
- Market Cap
- CDTX 229.0M
- FUND 236.5M
- IPO Year
- CDTX 2015
- FUND N/A
- Fundamental
- Price
- CDTX $21.70
- FUND $7.70
- Analyst Decision
- CDTX Strong Buy
- FUND
- Analyst Count
- CDTX 6
- FUND 0
- Target Price
- CDTX $32.20
- FUND N/A
- AVG Volume (30 Days)
- CDTX 127.4K
- FUND 32.5K
- Earning Date
- CDTX 11-07-2024
- FUND 01-01-0001
- Dividend Yield
- CDTX N/A
- FUND 6.64%
- EPS Growth
- CDTX N/A
- FUND N/A
- EPS
- CDTX N/A
- FUND 0.93
- Revenue
- CDTX $44,653,000.00
- FUND N/A
- Revenue This Year
- CDTX N/A
- FUND N/A
- Revenue Next Year
- CDTX N/A
- FUND N/A
- P/E Ratio
- CDTX N/A
- FUND $8.33
- Revenue Growth
- CDTX 44.48
- FUND N/A
- 52 Week Low
- CDTX $10.00
- FUND $6.75
- 52 Week High
- CDTX $28.42
- FUND $8.47
- Technical
- Relative Strength Index (RSI)
- CDTX 46.63
- FUND 58.39
- Support Level
- CDTX $19.87
- FUND $7.29
- Resistance Level
- CDTX $27.70
- FUND $7.56
- Average True Range (ATR)
- CDTX 2.33
- FUND 0.07
- MACD
- CDTX -0.79
- FUND 0.06
- Stochastic Oscillator
- CDTX 21.40
- FUND 97.96
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.